353 HIF-2 alpha targeting with a novel RNAi delivery platform as therapy for renal cell carcinoma. (September 2015) - Wong, S.; Cheng, W.; Wakefield, D.; Almeida, A.; Blokhin, A.; Almeida, L.; Hamilton, H.; Subbotin, V.; Hegge, J.; Bertin, S.; Milarch, T.; Schmidt, R.; et al.